Molecular Genetic Prediction of Opioid Analgesic Dosage Requirements in African-American Orthopedic Surgery Patients
Principal Investigators (PIs):
Henry Kranzler, MD Psychiatry
Martin Cheatle, PHD Psychiatry
Chemical-Genomic Screening to Enable Function Precision Medicine in Hepatocellular Carcinoma
Principal Investigators (PIs):
Terence Gade, MD, PHD Radiology
Junwei Shi, PHD Cancer Biology
Sarah Cherry, PHD Microbiology
Clinical Decision Making for AML Patients Using Algorithms
Principal Investigators (PIs):
Robert Faryabi, PHD, MSC Cancer Biology
Michael Feldman, MD, PHD Pathology and Labratory Medicine
Translating a Precision Medicine Approach for Treating Idiopathic Multicentric Castleman Disease into a Clinical Trial
Principal Investigator (PI):
David Fajgenbaum, MD, MBA, MSC Translational Medicine and Human Genetics
Translating Targeted Cellular Immunotherapies for Autoimmune Disease to Clinical Practice
Principal Investigators (PIs):
Aimee S. Payne, MD, PHD Dermatology
Mike Milone, MD, PHD Pathology and Laboratory Medicine
Advancing Diagnostic Precision in Patients with Non-Ischemic Cardiomyopathy
Principal Investigators (PIs):
Kenneth Margulies, MD Cardiology
Francis Marchlinski, MD Cardiology
PARPVAX: A Two Arm, Open Label Phase IB/II Trial of Maintenance Niraparib Plus Either Nivolumab or Ipilimumab in Patients with Advanced Pancreatic Cancer Who Have Achieved Durable Stability on Platinum-Based Chemotherapy
Principal Investigator (PI):
Kim Reiss Binder, MD Hematology/Oncology
Systematic, Automated Screening to Improve the Diagnosis and Management of Primary Aldosteronism
Principal Investigator (PI):
Daniel Herman, MD, PHD Pathology and Laboratory Medicine
Economics of Precision Medicine
Principal Investigator (PI):
Genny Kanter, PhD Medical Ethics and Health Policy
